Keyphrases
Initial Treatment
100%
Newly Diagnosed
100%
Veterans Health Administration
100%
Lower Urinary Tract Symptoms
100%
Medical Therapy
85%
Surgical Therapy
57%
Watchful Waiting
57%
Prostate-specific Antigen
28%
Medical Surgery
28%
Alpha-blockers
28%
5α-reductase Inhibitors
28%
United States
14%
Pharmacotherapy
14%
Comorbidity
14%
Combination Therapy
14%
Logistic Regression Model
14%
Patient Health
14%
Monotherapy
14%
Combined Therapy
14%
Surgical Treatment
14%
Regression Model
14%
Diagnosed Cases
14%
Patient Engagement
14%
Urologists
14%
Opportunities for Improvement
14%
Incident Cases
14%
Integrated Treatment
14%
Health System Factors
14%
Medicine and Dentistry
Combination Therapy
100%
Lower Urinary Tract Symptom
100%
Veterans Health
100%
Surgery
71%
Watchful Waiting
57%
Prostate Specific Antigen
28%
Alpha Adrenergic Receptor Blocking Agent
28%
Steroid 5alpha Reductase Inhibitor
28%
Health System
14%
Drug Therapy
14%
Health Care
14%
Combined Therapy
14%
Parasympatholytic
14%
Logistic Regression Analysis
14%
Urologist
14%
Monotherapy
14%
ICD-9-CM
14%
Comorbidity
14%
Nursing and Health Professions
Combination Therapy
100%
Health Care Management
100%
Lower Urinary Tract Symptom
100%
Surgery
71%
Watchful Waiting
57%
Prostate Specific Antigen
28%
Alpha Adrenergic Receptor Blocking Agent
28%
Steroid 5alpha Reductase Inhibitor
28%
Drug Therapy
14%
Cholinergic Receptor Blocking Agent
14%
Logistic Regression Analysis
14%
Urologist
14%
Monotherapy
14%
ICD-9-CM
14%
Integrated Health Care System
14%
Comorbidity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Lower Urinary Tract Symptom
100%
Prostate Specific Antigen
28%
Alpha Adrenergic Receptor Blocking Agent
28%
Steroid 5alpha Reductase Inhibitor
28%
Pharmacotherapy
14%
Cholinergic Receptor Blocking Agent
14%
Monotherapy
14%
ICD-9-CM
14%
Comorbidity
14%
Neuroscience
Prostate Specific Antigen
100%
5-Alpha-Reductase Inhibitor
100%
Alpha Blocker
100%
Comorbidity
50%